March 3, 2020 Licensing, IP, and Legal M&A, Partnerships Product Launch

JEOL USA highlights new strategic partnerships strengthening its position as world-leading instrument provider

2 March 2020, PEABODY, MA:  JEOL USA, a leader in developing instruments used to advance scientific research and technology, is pleased to highlight its latest key strategic partnerships at Pittcon 2020: Mass-Spectrometry: NETZSCH integrated Thermal Analysis GC/MS system Electron Microscopy: Acquisition of Integrated Dynamic Electron Solutions, Inc. NMR Spectroscopy: RIKEN-JEOL Collaboration Center and the Kyoto... Read more

March 2, 2020 Clinical Research/Diagn. Licensing, IP, and Legal

GE Healthcare completes transfer of ownership of its four diagnostic imaging agents from Daiichi Sankyo

Tokyo, Japan and Chicago, US (March 2nd, 2020) – GE Healthcare (Head Office: Chicago, US) today completed the transfer of ownership of its four diagnostic imaging agents in Japan from Daiichi Sankyo Company, Limited (Head Office: Chuo-ku Tokyo; Daiichi Sankyo). Effective immediately, the four imaging agents, previously managed by Daiichi Sankyo, will be owned and... Read more

February 27, 2020 Licensing, IP, and Legal Life Science Tools PAI Top-10

Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit relating to BGI’s “CoolMPS” sequencing products. The complaint was filed against BGI Genomics Co., Ltd., BGI Americas Corp., MGI Tech Co., Ltd., MGI Americas, Inc. and Complete Genomics Inc. in the United States District Court for the Northern District... Read more

February 26, 2020 Chemicals, Reagents & Kits Licensing, IP, and Legal

QIAGEN announces worldwide shipments of QIAstat-Dx test kits for SARS-CoV-2

Hilden, Germany, and Germantown, Maryland, February 26, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has shipped its newly developed QIAstat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation. The new kit detects the novel coronavirus SARS-CoV-2 and adds rapid Sample to Insight syndromic testing to QIAGEN’s... Read more

February 13, 2020 Atomic Spectroscopy Licensing, IP, and Legal

Luminex Corporation to Participate At Upcoming Healthcare Investor Conferences in March 2020

AUSTIN, Texas, Feb. 13, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President & CEO, and Harriss Currie, Senior Vice President of Finance and CFO, plan to participate at three investor conferences in March 2020. Morgan Stanley European MedTech & Services Conference in London, England on March 3, 2020: one-on-one investor meetings.... Read more

February 7, 2020 Atomic Spectroscopy Licensing, IP, and Legal

Pacific Biosciences Announces Retirement of Michael Phillips, SVP of Research and Development

MENLO PARK, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that Michael Phillips has decided to retire from his role as the company’s Senior Vice President of Research and Development as of April 1, 2020.Mr. Phillips has... Read more

February 6, 2020 Chromatography Lab Top-10 Licensing, IP, and Legal M&A, Partnerships PAI Top-10

Agilent Technologies Announces Twist Bioscience Agrees to Pay $22.5 Million Settlement in IP Litigation

Agilent Technologies Announces Twist Bioscience Agrees to Pay $22.5 Million Settlement in IP Litigation SANTA CLARA, California, February 06, 2020 Agilent Technologies Inc. (NYSE: A) today announced it has reached an agreement with Twist Bioscience under which Twist has agreed to pay Agilent a sum of $22.5 million to settle Agilent’s claims against Twist, as... Read more

February 6, 2020 Licensing, IP, and Legal

Roche’s risdiplam showed significant improvement in motor function in people aged 2-25 with type 2 or 3 spinal muscular atrophy

First placebo-controlled trial to include adults with SMA demonstrates risdiplam improved or stabilised motor function  Medically meaningful and statistically significant results in primary and key secondary endpoints Pivotal SUNFISH Part 2 study population represents broad, real-world spectrum of people living with SMA Basel, 06 February 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today presented... Read more

February 5, 2020 Environ, Ag./Food & Bev Licensing, IP, and Legal

Neogen’s Lansing Lab Services earns ISO 17025 accreditation

CONTACT: Tony Lupo, Neogen Senior Director of Technical Services517/372-9200; tlupo@neogen.com LANSING, Mich., Feb. 5, 2020 — Neogen announced today that its Laboratory Services Group in Lansing, Mich., has received ISO/IEC 17025:2017 accreditation from the American Association for Laboratory Accreditation (A2LA) — the highest recognized quality standard in the world for testing laboratories. Receiving the accreditation means that... Read more